| Literature DB >> 23007380 |
Giovanni Corso1, Edo Bottacchi, Guido Giardini, Marco Di Giovanni, Teodoro Meloni, Massimo Pesenti Campagnoni, Massimo Veronese Morosini.
Abstract
Our aim was to prospectively ascertain the incidence of first-ever stroke and ischaemic stroke subtypes, mortality, functional outcome and recurrence in northern Italy. We identified all possible cases of stroke (1st January 2004 and 31st December 2008). Multiple overlapping sources were used. Standard definitions for incident cases, pathological types and infarction subtypes were used. Patient characteristics were identified and analysed, case-fatality was ascertained from administrative databases, and outcome was assessed in all surviving patients by modified Rankin Scale. We identified 1,326 incident strokes. The pathological diagnosis was confirmed in 94% of cases. The incidence of first-ever stroke was 80.2 per 100,000 (95% CI 73-87) when adjusted to world population. The incidence of embolic stroke was significantly greater in women than in men (p < 0.001) whereas the incidence of atherothrombotic stroke was significantly greater in men than in women (p < 0.001). The case-fatality of incident strokes was 9.5% at 7 day, 16.1% at 28 day, and 29.9% at 1 year. Case-fatality of ischaemic stroke was lower than that of other pathological types (p < 0.0001). Hypertension was the most important risk factor, and atrial fibrillation was the most common in embolic stroke. Increasing age, female gender and embolic stroke subtypes were associated with an adverse outcome. Data on stroke incidence and case-fatality were similar to those of other high-income countries. However, differences were found in the distribution of risk factors and prognosis across the stroke types and ischaemic stroke subtypes. Gender differences in long-term functional outcomes were significant.Entities:
Mesh:
Year: 2012 PMID: 23007380 PMCID: PMC3719005 DOI: 10.1007/s10072-012-1185-8
Source DB: PubMed Journal: Neurol Sci ISSN: 1590-1874 Impact factor: 3.307
Incidence rates per 100,000 population of first-ever stroke, by age and sex in Aosta Valley, Italy in 2004–2008
| Men | Women | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Number at risk | Number of cases | Incidence rate (95 % CI) | Number at risk | Number of cases | Incidence rate (95 % CI) | Number at risk | Number of cases | Incidence rate (95 % CI) | |
| Age group (years) | |||||||||
| 0–44 | 33,745 | 34 | 20.2 (13.4–26.9) | 31,869 | 19 | 11.9 (6.6–17.3) | 65,614 | 53 | 16.2 (11.8–20.5) |
| 45–54 | 9,115 | 38 | 83.4 (56.9–109.9) | 8,777 | 21 | 47.9 (27.4–68.3) | 17,892 | 59 | 66 (49.1–82.8) |
| 55–64 | 7,933 | 97 | 244.5 (195.9–293.2) | 7,700 | 38 | 98.7 (67.3–130.1) | 15,633 | 135 | 172.7 (143.6–201.8) |
| 65–74 | 6,341 | 177 | 558.3 (476.3–640.3) | 7,171 | 123 | 343 (282.5–403.6) | 13,512 | 300 | 444 (393.9–494.2) |
| 75–84 | 3,623 | 220 | 1,214.5 (1,055–1,374) | 5,670 | 263 | 927.7 (816.1–1,039.3) | 9,293 | 483 | 1,039.5 (947.3–1,131.7) |
| ≥85 | 831 | 85 | 2,045.7 (1,615.3–2,476.2) | 2,328 | 211 | 1,812.7 (1,570.3–2,055.1) | 3,159 | 296 | 1,874 (1,662.5–2,085.5) |
| All | 61,588 | 651 | 211.4 (195.2–227.6) | 63,515 | 675 | 212.5 (196.5–228.6) | 125,103 | 1,326 | 212 (200.6–223.4) |
| Standardiseda | 228.7 (211.9–245.6) | 157 (143.2–170.8) | 189.3 (178.5–200) | ||||||
| Standardisedb | 100 (88.8–111.2) | 62.1 (53.4–70.8) | 80.2 (73.2–87.2) | ||||||
aAge-adjusted rate standardised to the Italian population
bAge-adjusted rate standardised to the world population
Pathological stroke types incidence per 100,000 by type, sex, and age in Aosta Valley, Italy in 2004–2008
| Number at risk | Ischaemic stroke | Primary intracerebral haemorrhage | Subarachnoid haemorrhage | Undefined stroke subtype | |||||
|---|---|---|---|---|---|---|---|---|---|
|
| Incidence rate (95 % CI) |
| Incidence rate (95 % CI) |
| Incidence rate (95 % CI) |
| Incidence rate (95 % CI) | ||
| Men | |||||||||
| 0–44 | 33,745 | 20 | 11.9 (6.7–17) | 4 | 2.4 (0–4.7) | 9 | 5.3 (1.8–8.8) | 1 | 0.6 (0–1.8) |
| 45–54 | 9,115 | 26 | 57 (35.1–79) | 8 | 17.6 (5.4–29.7) | 2 | 4.4 (0–10.5) | 2 | 4.4 (0–10.5) |
| 55–64 | 7,933 | 76 | 191.6 (148.6–234.6) | 12 | 30.3 (13.1–47.4) | 6 | 15.1 (3–27.2) | 3 | 7.6 (0–16.1) |
| 65–74 | 6,341 | 149 | 470 (394.7–545.2) | 19 | 59.9 (33–86.9) | 2 | 6.3 (0–15) | 7 | 22.1 (5.7–38.4) |
| 75–84 | 3,623 | 175 | 966 (823.6–1,108.5) | 31 | 171.1 (110.9–231.3) | 3 | 16.6 (0–35.3) | 11 | 60.7 (24.8–96.6) |
| ≥85 | 831 | 67 | 1,612.5 (1,229.5–1,995.5) | 10 | 240.7 (91.7–389.7) | 0 | 0 (0–0) | 8 | 192.5 (59.2–325.8) |
| Subtotal | 61,588 | 513 | 166.6 (152.2–181) | 84 | 27.3 (21.4–33.1) | 22 | 7.1 (4.2–10.1) | 32 | 10.4 (6.8–14) |
| Standardiseda | 180.4 (165.4–195.4) | 29.3 (23.2–35.3) | 7.1 (4.1–10) | 12 (8.2–15.9) | |||||
| Standardisedb | 41.1 (33.9–48.2) | 8.4 (5.1–11.6) | 5.7 (3–8.4) | 2.3 (0.6–4) | |||||
| Women | |||||||||
| 0–44 | 31,869 | 12 | 7.5 (3.3–11.8) | 3 | 1.9 (0–4) | 2 | 1.3 (0–3) | 2 | 1.3 (0–3) |
| 45–54 | 8,777 | 11 | 25.1 (10.3–39.9) | 2 | 4.6 (0–10.9) | 6 | 13.7 (2.7–24.6) | 2 | 4.6 (0–10.9) |
| 55–64 | 7,700 | 29 | 75.3 (47.9–102.7) | 1 | 2.6 (0–7.7) | 5 | 13 (1.6–24.4) | 3 | 7.8 (0–16.6) |
| 65–74 | 7,171 | 105 | 292.8 (236.9–348.8) | 9 | 25.1 (8.7–41.5) | 4 | 11.2 (0.2–22.1) | 5 | 13.9 (1.7–26.2) |
| 75–84 | 5,670 | 220 | 776 (673.9–878.2) | 27 | 95.2 (59.3–131.1) | 2 | 7.1 (0–16.8) | 14 | 49.4 (23.5–75.2) |
| ≥85 | 2,328 | 167 | 1,434.7 (1,218.7–1,650.7) | 20 | 171.8 (96.6–247.1) | 3 | 25.8 (0–54.9) | 21 | 180.4 (103.3–257.5) |
| Subtotal | 63,515 | 544 | 171.3 (156.9–185.7) | 62 | 19.5 (14.7–24.4) | 22 | 6.9 (4–9.8) | 47 | 14.8 (10.6–19) |
| Standardiseda | 125.9 (113.6–138.3) | 14.2 (10–18.3) | 6.2 (3.5–9) | 10.7 (7.1–14.2) | |||||
| Standardisedb | 47.8 (40.2–55.4) | 5.6 (3–8.3) | 4.3 (2–6.5) | 4.4 (2.1–6.7) | |||||
| Total | |||||||||
| 0–44 | 65,614 | 32 | 9.8 (6.4–13.1) | 7 | 2.1 (0.6–3.7) | 11 | 3.4 (1.4–5.3) | 3 | 0.9 (0–1.9) |
| 45–54 | 17,892 | 37 | 41.4 (28–54.7) | 10 | 11.2 (4.2–18.1) | 8 | 8.9 (2.7–15.1) | 4 | 4.5 (0.1–8.9) |
| 55–64 | 15,633 | 105 | 134.3 (108.7–160) | 13 | 16.6 (7.6–25.7) | 11 | 14.1 (5.8–22.4) | 6 | 7.7 (1.5–13.8) |
| 65–74 | 13,512 | 254 | 376 (329.8–422.1) | 28 | 41.4 (26.1–56.8) | 6 | 8.9 (1.8–16) | 12 | 17.8 (7.7–27.8) |
| 75–84 | 9,293 | 395 | 850.1 (766.6–933.6) | 58 | 124.8 (92.7–156.9) | 5 | 10.8 (1.3–20.2) | 25 | 53.8 (32.7–74.9) |
| ≥85 | 3,159 | 234 | 1,481.5 (1,293.1–1,669.9) | 30 | 189.9 (122–257.8) | 3 | 19 (0–40.5) | 29 | 183.6 (116.8–250.4) |
| Subtotal | 125,103 | 1,057 | 169 (158.8–179.2) | 146 | 23.3 (19.6–27.1) | 44 | 7 (5–9.1) | 79 | 12.6 (9.8–15.4) |
| Standardiseda | 150.6 (141–160.2) | 20.8 (17.2–24.4) | 6.7 (4.7–8.8) | 11.2 (8.6–13.8) | |||||
| Standardisedb | 61.5 (55.3–67.6) | 9 (6.7–11.4) | 5.3 (3.5–7.1) | 4.4 (2.8–6) | |||||
aAge-adjusted rate standardised to the Italian population
bAge-adjusted rate standardised to the world population
Incidence rates per 100,000 per year for different subtypes of ischaemic stroke by age and sex in Aosta Valley, Italy in 2004–2008
| Number at risk | Atherothrombotic | Embolic | Lacunar | Other | Undetermined | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Incidence rate (95 % CI) |
| Incidence rate (95 % CI) |
| Incidence rate (95 % CI) |
| Incidence rate (95 % CI) |
| Incidence rate (95 % CI) | ||
| Men | |||||||||||
| 0–44 | 33,745 | 0 | 0 (0–0) | 4 | 2.4 (0–4.7) | 0 | 0 (0–0) | 5 | 3 (0.4–5.6) | 11 | 6.5 (2.7–10.4) |
| 45–54 | 9,115 | 1 | 2.2 (0–6.5) | 5 | 11 (1.4–20.6) | 7 | 15.4 (4–26.7) | 4 | 8.8 (0.2–17.4) | 9 | 19.7 (6.8–32.6) |
| 55–64 | 7,933 | 13 | 32.8 (15–50.6) | 8 | 20.2 (6.2–34.1) | 31 | 78.2 (50.7–105.7) | 0 | 0 (0–0) | 24 | 60.5 (36.3–84.7) |
| 65–74 | 6,341 | 28 | 88.3 (55.6–121) | 29 | 91.5 (58.2–124.7) | 34 | 107.2 (71.2–143.3) | 2 | 6.3 (0–15) | 56 | 176.6 (130.4–222.8) |
| 75–84 | 3,623 | 37 | 204.2 (138.5–270) | 39 | 215.3 (147.8–282.8) | 30 | 165.6 (106.4–224.8) | 0 | 0 (0–0) | 69 | 380.9 (291.2–470.6) |
| ≥85 | 831 | 12 | 288.8 (125.6–452) | 21 | 505.4 (289.8–721) | 14 | 336.9 (160.7–513.1) | 0 | 0 (0–0) | 20 | 481.3 (270.9–691.8) |
| Subtotal | 61,588 | 91 | 29.6 (23.5–35.6) | 106 | 34.4 (27.9–41) | 116 | 37.7 (30.8–44.5) | 11 | 3.6 (1.5–5.7) | 189 | 61.4 (52.6–70.1) |
| Standardiseda | 32.2 (25.9–38.6) | 38.9 (32–45.9) | 40 (32.9–47.1) | 3.5 (1.4–5.6) | 65.7 (56.7–74.8) | ||||||
| Standardisedb | 11.8 (8–15.6) | 14.9 (10.6–19.2) | 17.5 (12.8–22.1) | 3.5 (1.4–5.6) | 28.8 (22.8–34.8) | ||||||
| Women | |||||||||||
| 0–44 | 31,869 | 0 | 0 (0–0) | 0 | 0 (0–0) | 0 | 0 (0–0) | 1 | 0.6 (0–1.9) | 11 | 6.9 (2.8–11) |
| 45–54 | 8,777 | 0 | 0 (0–0) | 3 | 6.8 (0–14.6) | 1 | 2.3 (0–6.7) | 1 | 2.3 (0–6.7) | 6 | 13.7 (2.7–24.6) |
| 55–64 | 7,700 | 2 | 5.2 (0–12.4) | 6 | 15.6 (3.1–28.1) | 5 | 13 (1.6–24.4) | 2 | 5.2 (0–12.4) | 14 | 36.4 (17.3–55.4) |
| 65–74 | 7,171 | 11 | 30.7 (12.6–48.8) | 26 | 72.5 (44.6–100.4) | 21 | 58.6 (33.5–83.6) | 1 | 2.8 (0–8.3) | 46 | 128.3 (91.2–165.3) |
| 75–84 | 5,670 | 30 | 105.8 (68–143.7) | 55 | 194 (142.8–245.2) | 45 | 158.7 (112.4–205.1) | 0 | 0 (0–0) | 90 | 317.5 (252–382.9) |
| ≥85 | 2,328 | 19 | 163.2 (89.9–236.6) | 70 | 601.4 (460.9–741.8) | 22 | 189 (110.1–267.9) | 0 | 0 (0–0) | 56 | 481.1 (355.4–606.8) |
| Subtotal | 63,515 | 62 | 19.5 (14.7–24.4) | 160 | 50.4 (42.6–58.2) | 94 | 29.6 (23.6–35.6) | 5 | 1.6 (0.2–3) | 223 | 70.2 (61–79.4) |
| Standardiseda | 13.9 (9.8–18) | 35.3 (28.8–41.9) | 21.8 (16.7–27) | 1.6 (0.2–2.9) | 53.4 (45.3–61.4) | ||||||
| Standardisedb | 4.4 (2.1–6.6) | 11.5 (7.8–15.3) | 7.5 (4.5–10.6) | 1.3 (0–2.5) | 23.1 (17.8–28.4) | ||||||
| Total | |||||||||||
| 0–44 | 65,614 | 0 | 0 (0–0) | 4 | 1.2 (0–2.4) | 0 | 0 (0–0) | 6 | 1.8 (0.4–3.3) | 22 | 6.7 (3.9–9.5) |
| 45–54 | 17,892 | 1 | 1.1 (0–3.3) | 8 | 8.9 (2.7–15.1) | 8 | 8.9 (2.7–15.1) | 5 | 5.6 (0.7–10.5) | 15 | 16.8 (8.3–25.3) |
| 55–64 | 15,633 | 15 | 19.2 (9.5–28.9) | 14 | 17.9 (8.5–27.3) | 36 | 46.1 (31–61.1) | 2 | 2.6 (0–6.1) | 38 | 48.6 (33.2–64.1) |
| 65–74 | 13,512 | 39 | 57.7 (39.6–75.8) | 55 | 81.4 (59.9–102.9) | 55 | 81.4 (59.9–102.9) | 3 | 4.4 (0–9.5) | 102 | 151 (121.7–180.3) |
| 75–84 | 9,293 | 67 | 144.2 (109.7–178.7) | 94 | 202.3 (161.4–243.2) | 75 | 161.4 (124.9–197.9) | 0 | 0 (0–0) | 159 | 342.2 (289.1–395.3) |
| ≥85 | 3,159 | 31 | 196.3 (127.2–265.3) | 91 | 576.1 (458.1–694.2) | 36 | 227.9 (153.6–302.3) | 0 | 0 (0–0) | 76 | 481.2 (373.2–589.1) |
| Subtotal | 125,103 | 153 | 24.5 (20.6–28.3) | 266 | 42.5 (37.4–47.6) | 210 | 33.6 (29–38.1) | 16 | 2.6 (1.3–3.8) | 412 | 65.9 (59.5–72.2) |
| Standardiseda | 21.6 (17.9–25.2) | 37.4 (32.7–42.2) | 30 (25.7–34.3) | 2.5 (1.3–3.8) | 59 (53–65) | ||||||
| Standardisedb | 7.7 (5.5–9.9) | 13.3 (10.4–16.2) | 12.3 (9.6–15) | 2.4 (1.2–3.6) | 25.8 (21.8–29.8) | ||||||
aAge-adjusted rate standardised to the Italian population
bAge-adjusted rate standardised to the world population
Risk factors among patients with first-ever stroke by pathological type and ischaemic stroke subtype in CARe Aosta Valley, Italy 2004–2008
| First-ever stroke | Ischaemic stroke | Primary intracerebral haemorrhage | Subarachnoid haemorrhage |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total ( | Total ( | Atherothrombotic ( | Embolic ( | Lacunar ( | Other ( | Undetermined ( | (9 | ( | ||||||||||||
| Baseline characteristic | ||||||||||||||||||||
| Mean (SD) age (years) | 75 (13.7) | 75.7 (12.7) | 77.8 (9.2) | 79.2 (11.3) | 74.7 (10.9) | 47.3 (17.9) | 74.3 (13.7) | 74 (14.8) | 58.4 (16.7) | <0.001 | ||||||||||
| Male sex | 651 | 49.1 % (46.4–51.8) | 513 | 48.5 % (45.5–51.5) | 83 | 58.9 % | 110 | 40.4 % | 114 | 55.6 % | 9 | 64.3 % | 197 | 46.4 % | 84 | 57.5 % | 22 | 50 % | 0.54 | |
| Premorbid medication | ||||||||||||||||||||
| Antihypertensive treatment | 694 | 52.3 % (49.6–55) | 585 | 55.3 % (52.3–58.3) | 84 | 59.6 % | 172 | 63.2 % | 120 | 58.5 % | 0 | 209 | 49.2 % | 74 | 50.7 % | 13 | 29.5 % | 0.0086 | ||
| Antiplatelet agent | 327 | 24.7 % (22.3–27) | 276 | 26.1 % (23.5–28.8) | 48 | 34 % | 75 | 27.6 % | 54 | 26.3 % | 0 | 99 | 23.3 % | 37 | 25.3 % | 3 | 6.8 % | 0.0256 | ||
| Anticoagulant | 99 | 7.5 % (6.1–8.9) | 76 | 7.2 % (5.6–8.7) | 4 | 2.8 % | 66 | 24.3 % | 0 | 0 | 6 | 1.4 % | 18 | 12.3 % | 3 | 6.8 % | 0.0802 | |||
| Lipid-lowering drug | 70 | 5.3 % (4.1–6.5) | 62 | 5.9 % (4.4–7.3) | 10 | 7.1 % | 10 | 3.7 % | 14 | 6.8 % | 0 | 28 | 6.6 % | 4 | 2.7 % | 1 | 2.3 % | 0.3287 | ||
| Premorbid risk factor | ||||||||||||||||||||
| Hypertension | 975 | 73.5 % (71.2–75.9) | 802 | 75.9 % (73.3–78.5) | 105 | 74.5 % | 212 | 77.9 % | 182 | 88.8 % | 3 | 21.4 % | 300 | 70.6 % | 120 | 82.2 % | 22 | 50 % | 0.0057 | |
| Diabetes mellitus | 225 | 17 % (14.9–19) | 200 | 18.9 % (16.6–21.3) | 33 | 23.4 % | 44 | 16.2 % | 53 | 25.9 % | 0 | 70 | 16.5 % | 17 | 11.6 % | 3 | 6.8 % | 0.0087 | ||
| Hypercholesterolemia | 375 | 28.3 % (25.9–30.7) | 340 | 32.2 % (29.3–35) | 48 | 34 % | 59 | 21.7 % | 85 | 41.5 % | 2 | 14.3 % | 146 | 34.4 % | 22 | 15.1 % | 3 | 6.8 % | <0.0001 | |
| Previous TIA | 110 | 8.3 % (6.8–9.8) | 99 | 9.4 % (7.6–11.1) | 15 | 10.6 % | 21 | 7.7 % | 26 | 12.7 % | 1 | 7.1 % | 36 | 8.5 % | 5 | 3.4 % | 0 | 0.0284 | ||
| Know previous atrial fibrillation | 266 | 20.1 % (17.9–22.2) | 235 | 22.2 % (19.7–24.7) | 10 | 7.1 % | 206 | 75.7 % | 1 | 0.5 % | 0 | 18 | 4.2 % | 23 | 15.8 % | 2 | 4.5 % | 0.0030 | ||
| Previous myocardial infarction | 152 | 11.5 % (9.7–13.2) | 134 | 12.7 % (10.7–14.7) | 29 | 20.6 % | 37 | 13.6 % | 19 | 9.3 % | 0 | 49 | 11.5 % | 13 | 8.9 % | 2 | 4.5 % | |||
| Current smoking | 191 | 14.4 % (12.5–16.3) | 167 | 15.8 % (13.6–18) | 33 | 23.4 % | 24 | 8.8 % | 46 | 22.4 % | 1 | 7.1 % | 66 | 15.5 % | 12 | 8.2 % | 4 | 9.1 % | 0.0889 | |
| Heavy drinker | 59 | 4.4 % (3.3–5.6) | 52 | 4.9 % (3.6–6.2) | 10 | 7.1 % | 9 | 3.3 % | 20 | 9.8 % | 0 | 13 | 3.1 % | 6 | 4.1 % | 0 | 0.2336 | |||
| BMI >30 (kg/m2) | 87 | 6.6 % (5.2–7.9) | 77 | 7.3 % (5.7–8.9) | 6 | 4.3 % | 18 | 6.6 % | 21 | 10.2 % | 0 | 32 | 7.5 % | 5 | 3.4 % | 1 | 2.3 % | 0.2246 | ||
* Statistical difference in the mean age was tested using analysis of variance; all other comparisons were tested by χ2 test
Case–fatality at 7 days, 28 days and 1 year in CARe Aosta Valley, Italy 2004–2008
| Case–fatality | ||||||
|---|---|---|---|---|---|---|
| Dead at 7 days | Dead at 28 days | Dead at 1 year | ||||
|
| Rate (95 % CI) |
| Rate (95 % CI) |
| Rate (95 % CI) | |
| First-ever stroke ( | 126 | 9.5 % (7.9–11.1) | 214 | 16.1 % (14.2–18.1) | 396 | 29.9 % (27.4–32.3) |
| Sex | ||||||
| Male | 55 | 8.4 % (6.3–10.6) | 97 | 14.9 % (12.2–17.6) | 187 | 28.7 % (25.2–32.2) |
| Female | 71 | 10.5 % (8.2–12.8) | 117 | 17.3 % (14.5–20.2) | 209 | 31 % (27.5–34.4) |
| | 0.2823 | 0.3423 | 0.5505 | |||
| Age group, years | ||||||
| 0–64 | 14 | 6.1 % (3–9.2) | 20 | 8.7 % (5.1–12.3) | 30 | 13 % (8.7–17.4) |
| 65–84 | 59 | 7.9 % (6–9.8) | 99 | 13.3 % (10.8–15.7) | 193 | 25.8 % (22.7–29) |
| ≥85 | 53 | 15.2 % (11.4–19) | 95 | 27.2 % (22.5–31.9) | 173 | 49.6 % (44.3–54.8) |
| | 0.0006 | <0.0001 | <0.0001 | |||
| Ischaemic stroke ( | 49 | 4.6 % (3.4–5.9) | 114 | 10.8 % (8.9–12.7) | 267 | 25.3 % (22.6–27.9) |
| Atherothrombotic ( | 1 | 0.7 % (0–1.9) | 10 | 6.5 % (2.6–10.5) | 28 | 18.3 % (12.2–24.4) |
| Embolic ( | 25 | 9.4 % (5.9–12.9) | 50 | 18.8 % (14.1–23.5) | 113 | 42.5 % (36.5–48.4) |
| Lacunar ( | 1 | 0.5 % (0–1.4) | 2 | 1 % (0–2.3) | 13 | 6.2 % (2.9–9.4) |
| Other ( | 0 | 1 | 6.2 % (0–18.1) | 1 | 6.2 % (0–18.1) | |
| Undefined ( | 22 | 5.3 % (3.2–7.5) | 51 | 12.4 % (9.2–15.6) | 112 | 27.2 % (22.9–31.5) |
| | <0.0001 | <0.0001 | <0.0001 | |||
| Primary intracerebral haemorrhage ( | 33 | 22.6 % (15.8–29.4) | 48 | 32.9 % (25.3–40.5) | 70 | 47.9 % (39.8–56) |
| Subarachnoid haemorrhage ( | 7 | 15.9 % (5.1–26.7) | 12 | 27.3 % (14.1–40.4) | 14 | 31.8 % (18.1–45.6) |
| Stroke of undetermined type ( | 37 | 46.8 % (35.8–57.8) | 40 | 50.6 % (39.6–61.7) | 45 | 57 % (46–67.9) |
|
| <0.0001 | <0.0001 | <0.0001 | |||
Statistical differences were tested by χ2 test
mRS at 3.7 years in CARe Aosta Valley, Italy 2004–2008
| mRS 0–2 | mRS 3–5 | |||
|---|---|---|---|---|
|
| Rate (95 % CI) |
| Rate (95 % CI) | |
| First-ever stroke | 530 | 69.7 % (66.5–73 | 230 | 30.3 % (27–33.5) |
| Sex | ||||
| Male | 291 | 75.8 % (71.5–80.1) | 93 | 24.2 % (19.9–28.5 |
| Female | 239 | 63.6. % (58.7–68.4) | 137 | 36.4 % (31.6–41.3) |
| | <0.001 | <0.001 | ||
| Age group, years | ||||
| 0–64 | 163 | 86.2 % (81.3–91.2) | 26 | 13.8 % (8.8–18.7) |
| 65–84 | 327 | 70.6 % (66.5–74.8) | 136 | 29.4 % (25.2–33.5) |
| ≥85 | 40 | 37 % (27.9–46.1) | 68 | 63 % (53.9–72.1) |
| | 0.0003 | <0.0001 | ||
| Ischaemic stroke | 455 | 70.4 % (66.9–74) | 191 | 29.6 % (26–33.1) |
| Atherothrombotic | 62 | 63.3 % (53.7–72.8) | 36 | 36.7 % (27.2–46.3) |
| Embolic | 69 | 56.6 % (47.8–65.4) | 53 | 43.4 % (34.6–52.2) |
| Lacunar | 127 | 75.1 % (68.6–81.7) | 42 | 24.9 % (18.3–31.4) |
| Other | 14 | 100 % (100–100) | 0 | |
| Undefined | 183 | 75.3 % (69.9–80.7) | 60 | 24.7 % (19.3–30.1) |
| | 0.3784 | 0.0090 | ||
| Primary intracerebral haemorrhage | 35 | 58.3 % (45.9–70.8) | 25 | 41.7 % (29.2–54.1) |
| Subarachnoid haemorrhage | 19 | 73.1 % (56–90.1) | 7 | 26.9 % (9.9–44) |
| Stroke of undetermined type | 21 | 75 % (59–91) | 7 | 25 % (9–41) |
|
| 0.8445 | 0.5358 | ||
Statistical differences were tested by χ2 test
Fig. 1Observed percentage surviving free of recurrent stroke after first-ever stroke in CARe, with common ischaemic subtypes
Fig. 2Rate ratios of age-adjusted (age-adjusted to world population) incidence rates for first-ever stoke in population-based studies in the last decade. Reference group is CARe. Circles are means and bar are 95 % CI